Drug Delivery Devices Market Outlook in Belgium to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Publisher Name » GlobalData
Published Date » 2011-05-19
No. Of Pages » 112
GlobalDatas new report, Drug Delivery Devices Market Outlook in Belgium to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections provides key market data on the Belgium Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Market size and company share data for Drug Delivery Devices market categories Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the Belgium Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc., CareFusion Corporation, B. Braun Melsungen AG and others.
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Belgium Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table of Content:
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Drug Delivery Devices In Belgium 12
3.1 Drug Delivery Devices, Market Segmentation 12
3.2 Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017 13
3.3 Drug Delivery Devices Market, Belgium, Revenue Mix ($m), 2010 15
3.4 Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010 16
3.5 Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017 22
3.6 Drug Delivery Devices, Belgium, Company Share (2009-2010) 27
4 Central Venous Catheters In Belgium 29
4.1 Central Venous Catheters, Market Segmentation 29
4.2 Central Venous Catheters Market, Belgium, Revenue Mix ($m), 2010 30
4.3 Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010 31
4.4 Central Venous Catheters Overall Revenue (2003-2017) 32
4.5 Central Venous Catheters Overall Volume (2003-2017) 36
4.6 Central Venous Catheters Average Price (2003-2017) 40
4.7 Central Venous Catheters Distribution Share (2009-2010) 41
4.8 Central Venous Catheters, Belgium, Company Share (2009-2010) 42
5 Infusion Systems In Belgium 44
5.1 Infusion Systems, Market Segmentation 44
5.2 Infusion Systems Market, Belgium, Revenue Mix ($m), 2010 45
5.3 Infusion Systems Market, Belgium, Segment Contribution (%), 2010 46
5.4 Infusion Systems Overall Revenue (2003-2017) 47
5.4.1 Syringe Pumps Revenue (2003-2017) 51
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 55
5.5 Infusion Systems Overall Volume (2003-2017) 59
5.5.1 Syringe Pumps Volume (2003-2017) 63
5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 66
5.6 Infusion Systems Average Price (2003-2017) 70
5.7 Infusion Systems Distribution Share (2009-2010) 71
5.8 Infusion Systems, Belgium, Company Share (2009-2010) 72
6 Metered Dose Inhaler Devices In Belgium 74
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 74
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 76
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 78
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 79
6.5 Metered Dose Inhaler Devices, Belgium, Company Share (2009-2010) 80
7 Needle Free Injections In Belgium 82
7.1 Needle Free Injections Overall Revenue (2003-2017) 82
7.2 Needle Free Injections Overall Volume (2003-2017) 84
7.3 Needle Free Injections Average Price (2003-2017) 86
7.4 Needle Free Injections Distribution Share (2009-2010) 87
7.5 Needle Free Injections, Belgium, Company Share (2009-2010) 88
8 Overview of Key Companies in Belgium Drug Delivery Devices Market 89
8.1 GlaxoSmithKline plc 89
8.1.1 Company Overview 89
8.1.2 Share in the Belgium Drug Delivery Devices Market 89
8.2 Boehringer Ingelheim GmbH 90
8.2.1 Company Overview 90
8.2.2 Share in the Belgium Drug Delivery Devices Market 90
8.3 AstraZeneca PLC 91
8.3.1 Company Overview 91
8.3.2 Share in the Belgium Drug Delivery Devices Market 91
8.4 Baxter International Inc. 92
8.4.1 Company Overview 92
8.4.2 Share in the Belgium Drug Delivery Devices Market 92
8.5 CareFusion Corporation 93
8.5.1 Company Overview 93
8.5.2 Share in the Belgium Drug Delivery Devices Market 93
8.6 B. Braun Melsungen AG 94
8.6.1 Company Overview 94
8.6.2 Share in the Belgium Drug Delivery Devices Market 94
8.7 Hospira, Inc. 95
8.7.1 Company Overview 95
8.8 Medtronic, Inc. 95
8.8.1 Company Overview 95
8.9 Teleflex Incorporated 96
8.9.1 Company Overview 96
8.10 Fresenius Kabi AG 96
8.10.1 Company Overview 96
8.11 Terumo Corporation 96
8.11.1 Company Overview 96
8.12 Smiths Medical 97
8.12.1 Company Overview 97
8.13 Edwards Lifesciences Corporation 97
8.13.1 Company Overview 97
8.14 3M Health Care 97
8.14.1 Company Overview 97
8.15 Consort Medical plc 98
8.15.1 Company Overview 98
8.16 Becton, Dickinson and Company 98
8.16.1 Company Overview 98
8.17 C. R. Bard, Inc. 98
8.17.1 Company Overview 98
8.18 Bioject Medical Technologies Inc. 99
8.18.1 Company Overview 99
8.19 Antares Pharma, Inc. 99
8.19.1 Company Overview 99
8.20 INJEX - Equidyne Systems 99
8.20.1 Company Overview 99
9 Drug Delivery Devices Market Pipeline Products 100
10 Appendix 105
10.1 Definitions of Markets Covered in the Report 106
10.1.1 Drug Delivery Devices 106
10.2 Research Methodology 109
10.3 Secondary Research 109
10.4 Primary Research 110
10.5 Models 110
10.6 Forecasts 111
10.7 Expert Panels 111
10.8 GlobalData Consulting 111
10.9 Currency Conversion 111
10.10 Contact Us 112
10.11 Disclaimer 112
Table 1: Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017 14
Table 2: Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010 16
Table 3: Drug Delivery Devices, Belgium Cross-Category Analysis, 2003-2017 17
Table 4: Drug Delivery Devices, Belgium, Overall Revenue ($m), Historic, 2003-2010 19
Table 5: Drug Delivery Devices, Belgium, Overall Revenue ($m), Forecast, 2010-2017 21
Table 6: Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017 22
Table 7: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2003-2010 24
Table 8: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2010-2017 26
Table 9: Drug Delivery Devices, Belgium, Company Share by Revenue ($m), 2009-2010 28
Table 10: Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010 31
Table 11: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Historic, 2003-2010 33
Table 12: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017 35
Table 13: Central Venous Catheters, Belgium, Volume (Units) by Segment, Historic, 2003-2010 37
Table 14: Central Venous Catheters, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 39
Table 15: Central Venous Catheters, Belgium, Average Price ($), Historic, 2003-2010 40
Table 16: Central Venous Catheters, Belgium, Average Price ($), Forecast, 2010-2017 40
Table 17: Central Venous Catheters, Belgium, Distribution Share by Revenue ($m), 2009-2010 41
Table 18: Central Venous Catheters, Belgium, Company Share by Revenue ($m), 2009-2010 43
Table 19: Infusion Systems Market, Belgium, Segment Contribution (%), 2010 46
Table 21: Infusion Systems, Belgium, Revenue ($m) by Segment, Historic, 2003-2010 48
Table 22: Infusion Systems, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017 50
Table 23: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52
Table 24: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54
Table 25: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Table 26: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Table 27: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2003-2010 60
Table 28: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 62
Table 29: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Table 30: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Table 31: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Table 32: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Table 33: Infusion Systems, Belgium, Average Price ($), Historic, 2003-2010 70
Table 34: Infusion Systems, Belgium, Average Price ($), Forecast, 2010-2017 70
Table 35: Infusion Systems, Belgium, Distribution Share by Revenue ($m), 2009-2010 71
Table 36: Infusion Systems, Belgium, Company Share by Revenue ($m), 2009-2010 73
Table 37: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Historic, 2003-2010 74
Table 38: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Forecast, 2010-2017 75
Table 39: Metered Dose Inhaler Devices, Belgium, Volume (Units), Historic, 2003-2010 76
Table 40: Metered Dose Inhaler Devices, Belgium, Volume (Units), Forecast, 2010-2017 77
Table 41: Metered Dose Inhaler Devices, Belgium, Average Price ($), Historic, 2003-2010 78
Table 42: Metered Dose Inhaler Devices, Belgium, Average Price ($), Forecast, 2010-2017 78
Table 43: Metered Dose Inhaler Devices, Belgium, Distribution Share by Revenue ($m), 2009-2010 79
Table 44: Metered Dose Inhaler Devices, Belgium, Company Share by Revenue ($m), 2009-2010 81
Table 45: Needle Free Injections, Belgium, Revenue ($m), Historic, 2003-2010 82
Table 46: Needle Free Injections, Belgium, Revenue ($m), Forecast, 2010-2017 83
Table 47: Needle Free Injections, Belgium, Volume (Units), Historic, 2003-2010 84
Table 48: Needle Free Injections, Belgium, Volume (Units), Forecast, 2010-2017 85
Table 49: Needle Free Injections, Belgium, Average Price ($), Historic, 2003-2010 86
Table 50: Needle Free Injections, Belgium, Average Price ($), Forecast, 2010-2017 86
Table 51: Needle Free Injections, Belgium, Distribution Share by Revenue ($m), 2009-2010 87
Table 52: Needle Free Injections, Belgium, Company Share by Revenue ($m), 2009-2010 88
Table 53: Drug Delivery Devices Market Pipeline Products 100
Table 54: USD to Local Currency, Belgium, Average Actual Rate 2003-2010 111
Figure 1: Drug Delivery Devices, Market Segmentation 12
Figure 2: Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017 13
Figure 3: Drug Delivery Devices Market, Belgium, Revenue Mix ($m), 2010 15
Figure 4: Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010 16
Figure 5: Drug Delivery Devices Market, Belgium, Cross-Category Analysis, 2003-2017 17
Figure 6: Drug Delivery Devices, Belgium, Overall Revenue ($m), Historic, 2003-2010 18
Figure 7: Drug Delivery Devices, Belgium, Overall Revenue ($m), Forecast, 2010-2017 20
Figure 8: Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017 22
Figure 9: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2003-2010 23
Figure 10: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2010-2017 25
Figure 11: Drug Delivery Devices, Belgium, Company Share (%), 2010 27
Figure 12: Central Venous Catheters, Market Segmentation 29
Figure 13: Central Venous Catheters Market, Belgium, Revenue Mix ($m), 2010 30
Figure 14: Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010 31
Figure 15: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Historic, 2003-2010 32
Figure 16: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017 34
Figure 17: Central Venous Catheters, Belgium, Volume (Units) by Segment, Historic, 2003-2010 36
Figure 18: Central Venous Catheters, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 38
Figure 19: Central Venous Catheters, Belgium, Company Share (%), 2010 42
Figure 20: Infusion Systems, Market Segmentation 44
Figure 21: Infusion Systems Market, Belgium, Revenue Mix ($m), 2010 45
Figure 22: Infusion Systems Market, Belgium, Segment Contribution (%), 2010 46
Figure 23: Infusion Systems, Belgium, Revenue ($m) by Segment, Historic, 2003-2010 47
Figure 24: Infusion Systems, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017 49
Figure 25: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51
Figure 26: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53
Figure 27: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55
Figure 28: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57
Figure 29: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2003-2010 59
Figure 30: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 61
Figure 31: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 63
Figure 32: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Figure 33: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Figure 34: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 35: Infusion Systems, Belgium, Company Share (%), 2010 72
Figure 36: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Historic, 2003-2010 74
Figure 37: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Forecast, 2010-2017 75
Figure 38: Metered Dose Inhaler Devices, Belgium, Volume (Units), Historic, 2003-2010 76
Figure 39: Metered Dose Inhaler Devices, Belgium, Volume (Units), Forecast, 2010-2017 77
Figure 40: Metered Dose Inhaler Devices, Belgium, Company Share (%), 2010 80
Figure 41: Needle Free Injections, Belgium, Revenue ($m), Historic, 2003-2010 82
Figure 42: Needle Free Injections, Belgium, Revenue ($m), Forecast, 2010-2017 83
Figure 43: Needle Free Injections, Belgium, Volume (Units), Historic, 2003-2010 84
Figure 44: Needle Free Injections, Belgium, Volume (Units), Forecast, 2010-2017 85
Figure 45: Needle Free Injections, Belgium, Company Share (%), 2010 88
Figure 46: GlaxoSmithKline plc, Company Share (%),Belgium Drug Delivery Devices Market, 2010 89
Figure 47: Boehringer Ingelheim GmbH, Company Share (%),Belgium Drug Delivery Devices Market, 2010 90
Figure 48: AstraZeneca PLC., Company Share (%),Belgium Drug Delivery Devices Market, 2010 91
Figure 49: Baxter International Inc., Company Share (%),Belgium Drug Delivery Devices Market, 2010 92
Figure 50: CareFusion Corporation, Company Share (%),Belgium Drug Delivery Devices Market, 2010 93
Figure 51: B. Braun Melsungen AG, Company Share (%),Belgium Drug Delivery Devices Market, 2010 94
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Drug Delivery Devices In Belgium 12
3.1 Drug Delivery Devices, Market Segmentation 12
3.2 Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017 13
3.3 Drug Delivery Devices Market, Belgium, Revenue Mix ($m), 2010 15
3.4 Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010 16
3.5 Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017 22
3.6 Drug Delivery Devices, Belgium, Company Share (2009-2010) 27
4 Central Venous Catheters In Belgium 29
4.1 Central Venous Catheters, Market Segmentation 29
4.2 Central Venous Catheters Market, Belgium, Revenue Mix ($m), 2010 30
4.3 Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010 31
4.4 Central Venous Catheters Overall Revenue (2003-2017) 32
4.5 Central Venous Catheters Overall Volume (2003-2017) 36
4.6 Central Venous Catheters Average Price (2003-2017) 40
4.7 Central Venous Catheters Distribution Share (2009-2010) 41
4.8 Central Venous Catheters, Belgium, Company Share (2009-2010) 42
5 Infusion Systems In Belgium 44
5.1 Infusion Systems, Market Segmentation 44
5.2 Infusion Systems Market, Belgium, Revenue Mix ($m), 2010 45
5.3 Infusion Systems Market, Belgium, Segment Contribution (%), 2010 46
5.4 Infusion Systems Overall Revenue (2003-2017) 47
5.4.1 Syringe Pumps Revenue (2003-2017) 51
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 55
5.5 Infusion Systems Overall Volume (2003-2017) 59
5.5.1 Syringe Pumps Volume (2003-2017) 63
5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 66
5.6 Infusion Systems Average Price (2003-2017) 70
5.7 Infusion Systems Distribution Share (2009-2010) 71
5.8 Infusion Systems, Belgium, Company Share (2009-2010) 72
6 Metered Dose Inhaler Devices In Belgium 74
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 74
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 76
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 78
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 79
6.5 Metered Dose Inhaler Devices, Belgium, Company Share (2009-2010) 80
7 Needle Free Injections In Belgium 82
7.1 Needle Free Injections Overall Revenue (2003-2017) 82
7.2 Needle Free Injections Overall Volume (2003-2017) 84
7.3 Needle Free Injections Average Price (2003-2017) 86
7.4 Needle Free Injections Distribution Share (2009-2010) 87
7.5 Needle Free Injections, Belgium, Company Share (2009-2010) 88
8 Overview of Key Companies in Belgium Drug Delivery Devices Market 89
8.1 GlaxoSmithKline plc 89
8.1.1 Company Overview 89
8.1.2 Share in the Belgium Drug Delivery Devices Market 89
8.2 Boehringer Ingelheim GmbH 90
8.2.1 Company Overview 90
8.2.2 Share in the Belgium Drug Delivery Devices Market 90
8.3 AstraZeneca PLC 91
8.3.1 Company Overview 91
8.3.2 Share in the Belgium Drug Delivery Devices Market 91
8.4 Baxter International Inc. 92
8.4.1 Company Overview 92
8.4.2 Share in the Belgium Drug Delivery Devices Market 92
8.5 CareFusion Corporation 93
8.5.1 Company Overview 93
8.5.2 Share in the Belgium Drug Delivery Devices Market 93
8.6 B. Braun Melsungen AG 94
8.6.1 Company Overview 94
8.6.2 Share in the Belgium Drug Delivery Devices Market 94
8.7 Hospira, Inc. 95
8.7.1 Company Overview 95
8.8 Medtronic, Inc. 95
8.8.1 Company Overview 95
8.9 Teleflex Incorporated 96
8.9.1 Company Overview 96
8.10 Fresenius Kabi AG 96
8.10.1 Company Overview 96
8.11 Terumo Corporation 96
8.11.1 Company Overview 96
8.12 Smiths Medical 97
8.12.1 Company Overview 97
8.13 Edwards Lifesciences Corporation 97
8.13.1 Company Overview 97
8.14 3M Health Care 97
8.14.1 Company Overview 97
8.15 Consort Medical plc 98
8.15.1 Company Overview 98
8.16 Becton, Dickinson and Company 98
8.16.1 Company Overview 98
8.17 C. R. Bard, Inc. 98
8.17.1 Company Overview 98
8.18 Bioject Medical Technologies Inc. 99
8.18.1 Company Overview 99
8.19 Antares Pharma, Inc. 99
8.19.1 Company Overview 99
8.20 INJEX - Equidyne Systems 99
8.20.1 Company Overview 99
9 Drug Delivery Devices Market Pipeline Products 100
10 Appendix 105
10.1 Definitions of Markets Covered in the Report 106
10.1.1 Drug Delivery Devices 106
10.2 Research Methodology 109
10.3 Secondary Research 109
10.4 Primary Research 110
10.5 Models 110
10.6 Forecasts 111
10.7 Expert Panels 111
10.8 GlobalData Consulting 111
10.9 Currency Conversion 111
10.10 Contact Us 112
10.11 Disclaimer 112
List of Tables
Table 1: Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017 14
Table 2: Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010 16
Table 3: Drug Delivery Devices, Belgium Cross-Category Analysis, 2003-2017 17
Table 4: Drug Delivery Devices, Belgium, Overall Revenue ($m), Historic, 2003-2010 19
Table 5: Drug Delivery Devices, Belgium, Overall Revenue ($m), Forecast, 2010-2017 21
Table 6: Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017 22
Table 7: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2003-2010 24
Table 8: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2010-2017 26
Table 9: Drug Delivery Devices, Belgium, Company Share by Revenue ($m), 2009-2010 28
Table 10: Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010 31
Table 11: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Historic, 2003-2010 33
Table 12: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017 35
Table 13: Central Venous Catheters, Belgium, Volume (Units) by Segment, Historic, 2003-2010 37
Table 14: Central Venous Catheters, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 39
Table 15: Central Venous Catheters, Belgium, Average Price ($), Historic, 2003-2010 40
Table 16: Central Venous Catheters, Belgium, Average Price ($), Forecast, 2010-2017 40
Table 17: Central Venous Catheters, Belgium, Distribution Share by Revenue ($m), 2009-2010 41
Table 18: Central Venous Catheters, Belgium, Company Share by Revenue ($m), 2009-2010 43
Table 19: Infusion Systems Market, Belgium, Segment Contribution (%), 2010 46
Table 21: Infusion Systems, Belgium, Revenue ($m) by Segment, Historic, 2003-2010 48
Table 22: Infusion Systems, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017 50
Table 23: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52
Table 24: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54
Table 25: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Table 26: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Table 27: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2003-2010 60
Table 28: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 62
Table 29: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Table 30: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Table 31: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Table 32: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Table 33: Infusion Systems, Belgium, Average Price ($), Historic, 2003-2010 70
Table 34: Infusion Systems, Belgium, Average Price ($), Forecast, 2010-2017 70
Table 35: Infusion Systems, Belgium, Distribution Share by Revenue ($m), 2009-2010 71
Table 36: Infusion Systems, Belgium, Company Share by Revenue ($m), 2009-2010 73
Table 37: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Historic, 2003-2010 74
Table 38: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Forecast, 2010-2017 75
Table 39: Metered Dose Inhaler Devices, Belgium, Volume (Units), Historic, 2003-2010 76
Table 40: Metered Dose Inhaler Devices, Belgium, Volume (Units), Forecast, 2010-2017 77
Table 41: Metered Dose Inhaler Devices, Belgium, Average Price ($), Historic, 2003-2010 78
Table 42: Metered Dose Inhaler Devices, Belgium, Average Price ($), Forecast, 2010-2017 78
Table 43: Metered Dose Inhaler Devices, Belgium, Distribution Share by Revenue ($m), 2009-2010 79
Table 44: Metered Dose Inhaler Devices, Belgium, Company Share by Revenue ($m), 2009-2010 81
Table 45: Needle Free Injections, Belgium, Revenue ($m), Historic, 2003-2010 82
Table 46: Needle Free Injections, Belgium, Revenue ($m), Forecast, 2010-2017 83
Table 47: Needle Free Injections, Belgium, Volume (Units), Historic, 2003-2010 84
Table 48: Needle Free Injections, Belgium, Volume (Units), Forecast, 2010-2017 85
Table 49: Needle Free Injections, Belgium, Average Price ($), Historic, 2003-2010 86
Table 50: Needle Free Injections, Belgium, Average Price ($), Forecast, 2010-2017 86
Table 51: Needle Free Injections, Belgium, Distribution Share by Revenue ($m), 2009-2010 87
Table 52: Needle Free Injections, Belgium, Company Share by Revenue ($m), 2009-2010 88
Table 53: Drug Delivery Devices Market Pipeline Products 100
Table 54: USD to Local Currency, Belgium, Average Actual Rate 2003-2010 111
List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 12
Figure 2: Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017 13
Figure 3: Drug Delivery Devices Market, Belgium, Revenue Mix ($m), 2010 15
Figure 4: Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010 16
Figure 5: Drug Delivery Devices Market, Belgium, Cross-Category Analysis, 2003-2017 17
Figure 6: Drug Delivery Devices, Belgium, Overall Revenue ($m), Historic, 2003-2010 18
Figure 7: Drug Delivery Devices, Belgium, Overall Revenue ($m), Forecast, 2010-2017 20
Figure 8: Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017 22
Figure 9: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2003-2010 23
Figure 10: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2010-2017 25
Figure 11: Drug Delivery Devices, Belgium, Company Share (%), 2010 27
Figure 12: Central Venous Catheters, Market Segmentation 29
Figure 13: Central Venous Catheters Market, Belgium, Revenue Mix ($m), 2010 30
Figure 14: Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010 31
Figure 15: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Historic, 2003-2010 32
Figure 16: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017 34
Figure 17: Central Venous Catheters, Belgium, Volume (Units) by Segment, Historic, 2003-2010 36
Figure 18: Central Venous Catheters, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 38
Figure 19: Central Venous Catheters, Belgium, Company Share (%), 2010 42
Figure 20: Infusion Systems, Market Segmentation 44
Figure 21: Infusion Systems Market, Belgium, Revenue Mix ($m), 2010 45
Figure 22: Infusion Systems Market, Belgium, Segment Contribution (%), 2010 46
Figure 23: Infusion Systems, Belgium, Revenue ($m) by Segment, Historic, 2003-2010 47
Figure 24: Infusion Systems, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017 49
Figure 25: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51
Figure 26: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53
Figure 27: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55
Figure 28: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57
Figure 29: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2003-2010 59
Figure 30: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 61
Figure 31: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 63
Figure 32: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Figure 33: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Figure 34: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 35: Infusion Systems, Belgium, Company Share (%), 2010 72
Figure 36: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Historic, 2003-2010 74
Figure 37: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Forecast, 2010-2017 75
Figure 38: Metered Dose Inhaler Devices, Belgium, Volume (Units), Historic, 2003-2010 76
Figure 39: Metered Dose Inhaler Devices, Belgium, Volume (Units), Forecast, 2010-2017 77
Figure 40: Metered Dose Inhaler Devices, Belgium, Company Share (%), 2010 80
Figure 41: Needle Free Injections, Belgium, Revenue ($m), Historic, 2003-2010 82
Figure 42: Needle Free Injections, Belgium, Revenue ($m), Forecast, 2010-2017 83
Figure 43: Needle Free Injections, Belgium, Volume (Units), Historic, 2003-2010 84
Figure 44: Needle Free Injections, Belgium, Volume (Units), Forecast, 2010-2017 85
Figure 45: Needle Free Injections, Belgium, Company Share (%), 2010 88
Figure 46: GlaxoSmithKline plc, Company Share (%),Belgium Drug Delivery Devices Market, 2010 89
Figure 47: Boehringer Ingelheim GmbH, Company Share (%),Belgium Drug Delivery Devices Market, 2010 90
Figure 48: AstraZeneca PLC., Company Share (%),Belgium Drug Delivery Devices Market, 2010 91
Figure 49: Baxter International Inc., Company Share (%),Belgium Drug Delivery Devices Market, 2010 92
Figure 50: CareFusion Corporation, Company Share (%),Belgium Drug Delivery Devices Market, 2010 93
Figure 51: B. Braun Melsungen AG, Company Share (%),Belgium Drug Delivery Devices Market, 2010 94
Upcoming Reports:
|
Bio-Based Levulinic Acid Market - Global Industry Analysis, Potential Applications, Downstream Derivatives Market Size, Share, Trends, Growth And Forecast 2009 - 2019
By - Transparency Market Research
New molecules developed by Segetis, in Minnesota based on esters of levulinic acid made from using bio based hydroxyl compounds and corn cobs are known as levulinic ketals. These can be used to produce a series of products such as plasticizers, polyols for polyurethane foams and solvents. Segetis are constructing a new toll manufacturing plant for their new ketals chemistry in the Midwest and the construction of which was expected to be completed by the end of 2011. Products entering the market would start with solvents. While polyols is expected to be the last to enter in...
|
|
Polyacrylamide Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast, 2012 - 2018
By - Transparency Market Research
Description
Polyacrylamide is a kind of polymer that is formed by mutually crossing link with an acrylic amide. Polyacrylamide is also known to be formed out of the acrylamide subunits. It is economic, environment friendly, and being versatile it is used in different industries. It is non toxic, however, non polymerized acrylamide may be present in a small amount in polymerized acrylamide which is a neurotoxin and is handled with care. Polyacrylamide consist copolymers of acrylamide and certain few other chemical species like acrylic acid or salt.
The financial...
|
|
Smart Materials Application and Technologies Market - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Smart materials are referred to materials whose properties can be modified according to the given requirements by means of stress, temperature, light, electric potential difference, pH or a strong magnetic field. There is wide range of smart material varieties with various properties that make a material well suited for a particular use. Some common examples of smart materials include piezoelectric materials, temperature responsive polymers, photomechanical materials, and dielectric elastomers among some others.
The global market for smart materials was estimated to be...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- Electricity Meters (Smart Meters) Market For Residential, Commercial And Industrial Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Bed Linen Markets in the World to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Eastern Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Western Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Asia to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Americas to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Africa to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 10 Global Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 European Countries to 2017 - Market Size, Trends, and Forecasts
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
